Welcome to our dedicated page for LanzaTech Global news (Ticker: LNZA), a resource for investors and traders seeking the latest updates and insights on LanzaTech Global stock.
LanzaTech Global, Inc. (NASDAQ: LNZA) regularly publishes news that centers on carbon management, carbon recycling and the commercialization of its gas‑fermentation technology. The LNZA news feed on Stock Titan aggregates company press releases and related coverage so readers can follow how LanzaTech is applying its platform to industrial emissions, gasified solid waste, municipal solid waste and captured CO₂.
Recent announcements highlight project milestones, technology performance and strategic partnerships. Examples include operational results from a municipal solid waste‑to‑ethanol pilot plant in Kuji City, Japan, where LanzaTech’s fermentation technology processed mixed non‑recyclable waste streams, and updates on an integrated CCUS project in Norway supported by the EU Innovation Fund and Enova SF. LanzaTech also reports on UK government grant funding for its DRAGON 1 & 2 sustainable aviation fuel projects, which integrate its gas fermentation with LanzaJet’s Alcohol‑to‑Jet technology.
Investors and industry observers can use the LNZA news page to track developments in sustainable aviation fuel, low‑carbon fuels and chemicals, and collaborations with partners such as LanzaJet, the Mibelle Group and Fraunhofer IGB. News items also cover financial results, capital structure changes like the reverse stock split, and amendments to key investment and license agreements. Together, these updates provide context on LanzaTech’s progress in moving from a research and development‑centric organization toward a commercially focused enterprise.
By reviewing the LNZA news feed, readers gain insight into how LanzaTech’s technology is being deployed across regions and sectors, how its project pipeline is evolving, and how it positions its carbon recycling platform within the broader push for a circular carbon economy.
LanzaTech (NASDAQ: LNZA) plans a £600 million DRAGON II sustainable aviation fuel and renewable diesel facility at px Saltend Chemicals Park in Humberside.
The project targets ~80,000 tonnes of SAF (~1% of UK jet fuel) and 8,000 tonnes of renewable diesel annually, with construction expected H2 2027 and operations by 2030, supporting ~300 construction jobs and ~150 operational roles.
LanzaTech (NASDAQ: LNZA) was awarded a contract by Spray Engineering Devices Ltd to build a next-generation ethanol facility in Uttar Pradesh, India, as part of the SED Smart Village initiative.
The plant will use LanzaTech's carbon recycling bioreactor technology to convert syngas from oxygen-enriched air gasification of sugarcane bagasse (processed up to 300 tons per day) into ethanol and produce 5–10% nutrient-rich biochar. The facility is expected to begin operations within two years and will operate under the PM JI-VAN Yojana program, advancing local fuel and chemical production from waste-based feedstocks.
LanzaTech (NASDAQ: LNZA) closed a $20 million private placement of common stock on Jan. 22, 2026, with participation from new investor SiteGround and other institutional investors.
The company referenced a prior $40 million investment in May 2025 and cited awarded grants including a €40 million EU Innovation Fund grant (pending final agreement) and a £6.4 million UK Advanced Fuels Fund grant to advance CCUS and sustainable aviation fuel projects. LanzaJet, where LanzaTech holds a non-controlling majority stake, began commercial ethanol-to-jet operations. Shares issued are unregistered under the Securities Act and restricted from resale except under registration or applicable exemptions.
LanzaTech (NASDAQ: LNZA) reported that its Kuji, Japan MSW-to-ethanol pilot (1/10th commercial, ~400 tons ethanol/year) sustained specific ethanol yields above guaranteed performance for over 14 consecutive days at steady state. The nearly four-year-operated facility processed highly inhomogeneous waste-derived syngas with combined CO+H₂ content of 40%–55% and an H₂:CO ratio of 1.1–1.4, demonstrating the fermentation platform's robustness and adaptability to variable waste feeds and gasifier designs.
LanzaTech (NASDAQ: LNZA) increased its ownership in LanzaJet to 53%, following receipt of final tranches of common stock on December 16, 2025.
The issuances were the final equity tranches under the Second Amended & Restated LanzaJet Investment Agreement and were issued under pre-agreed terms without new capital investment. LanzaJet’s Freedom Pines Fuels facility in Soperton, Georgia, is producing ASTM-certified SPK and Renewable Diesel, marking the world’s first commercial-scale jet fuel from ethanol. The companies cite potential aviation emissions reductions of up to 85% using diverse domestic and waste feedstocks. LanzaTech said the interest is accounted for under the equity method, and that the increased stake does not change governance or control.
LanzaTech (NASDAQ: LNZA) reported third quarter 2025 results for the period ended September 30, 2025. Key operational milestones include the LanzaJet Freedom Pines ethanol-to-jet plant reaching commercial operation in November 2025 and an awarded €40 million EU Innovation Fund grant for an integrated CCUS project in Norway, subject to final agreement in spring 2026.
Financial highlights: Q3 revenue $9.3M, Q3 net income $2.9M versus a $57.4M loss a year earlier, Adjusted EBITDA loss $13.5M (improved versus prior year), and cash, restricted cash and investments $23.5M as of September 30, 2025.
LanzaTech (NASDAQ: LNZA) announced on November 13, 2025 that LanzaJet’s Freedom Pines Fuels facility in Soperton, Georgia, is fully operational and has produced jet fuel at commercial scale using ethanol as feedstock.
This marks the world’s first commercial-scale ethanol-to-jet production and the first renewable jet solution compatible with current aircraft that does not rely on lipids or oils. The company highlighted ethanol’s ability to be made from diverse domestic and recycled carbon feedstocks and named multiple strategic investors and supporters backing LanzaJet’s commercialization and global rollout.
LanzaTech (NASDAQ: LNZA) secured a €40 million EU Innovation Fund grant (subject to finalizing the grant agreement) to deploy a first commercial second-generation bioreactor at Eramet Norway's Porsgrunn manganese smelter.
The project aims to produce 23.5 kt (~8M US gallons) ethanol per year from CO-rich furnace gas and, if fully implemented with carbon capture and storage, target up to a 97% emissions reduction with an annual GHG avoidance of 1,698,175 tons CO2e. A concentrated CO2 co-product will be purified, liquefied and transported for permanent geological storage in the North Sea. Enova provided funding and technical support as Norway's National Contact Point.
LanzaTech (NASDAQ: LNZA) announced that investors in affiliate LanzaJet agreed to Second Amended and Restated Investment and Stockholders’ Agreements to accelerate commercial rollout of sustainable aviation fuel (SAF).
Key changes: LanzaTech can receive two tranches of LanzaJet shares upon Freedom Pines development milestones; if LanzaJet is sold or goes public before those tranches are delivered, LanzaTech's stake will automatically rise to 50% without further investment. The companies also amended the 2020 IP and Technology License Agreement, extending it through December 31, 2031, removing LanzaTech’s termination right, requiring LanzaTech to transfer the license to LanzaJet, and eliminating restrictions on sublicensing LanzaJet technology.
LanzaTech (NASDAQ: LNZA) has announced a breakthrough technology development in collaboration with Mibelle Group and Fraunhofer IGB to produce a sustainable palm oil substitute. The innovative dual fermentation technology transforms waste CO2 gases into alcohol and then into palm oil-like fat using non-GMO oil yeasts.
This advancement has dual significance: it offers an alternative to palm oil in cosmetics while potentially expanding feedstock options for Sustainable Aviation Fuel (SAF) production through the Hydroprocessed Esters and Fatty Acids (HEFA) pathway. The technology has successfully completed laboratory trials at Fraunhofer IGB and application tests at Mibelle laboratories, with scaling efforts now underway at Fraunhofer's Center for Chemical-Biotechnological Processes in Leuna.